Guggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company's obesity drug candidates.

Set on La Gorce Island, a Miami Beach residence listed for $88 million—dubbed Okto—spans nearly 16,000 square feet with 260 ...

Guggenheim initiated coverage of Sportradar (SRAD) with a Buy rating and $27 price target Discover the Best Stocks and Maximize Your Portfolio: ...

Wingstop (NASDAQ:WING – Get Free Report) was upgraded by analysts at Guggenheim from a “neutral” rating to a “buy” rating in ...

"Our alliance with Luminis Partners is an important component of our broader international focus to provide clients with strategic opportunities,” said Mark Van Lith, CEO of Guggenheim Securities. "We ...

We recently published a list of 10 Best Retirement Stocks to Buy According to Hedge Funds. In this article, we are going to ...

From sweeping curves to industrial structures, visionary architects have reimagined museums as more than just spaces to view ...

Guggenheim reaffirmed their buy rating on shares of CyberArk Software (NASDAQ:CYBR – Free Report) in a research note issued ...

It was not your typical smash-and-grab burglary and the booty was precious: a toilet worth more than its weight in gold.

We recently published a list of 10 Best Retirement Stocks to Buy According to Hedge Funds. In this article, we are going to ...

To what extent is the famous Italian art movement Arte Povera a ‘poor art’ rebellion or a rich man’s game? After a major ...